ÂÜÀòÂÒÂ×

David Pyott is the current advisor at Anivive. David has previously worked as the CEO of both BioMarin Pharmaceutical Inc. and Alnylam Pharmaceuticals. David has also been a part of Philips, the Ophthalmology Foundation, the Foundation of American Academy of Opthalmology, and the Pan-American Association of Ophthalmology. David has dedicated their life to helping others and continues to do so through their work with Anivive.

David Pyott has a Master of Business Administration (MBA) from the London Business School, a Diploma in European and International Trade Law from the University of Amsterdam, and a Master of Arts (M.A.) from the University of Edinburgh. David also has an honorary degree in medicine from the University of Edinburgh.